Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. USO
7. GOOGL
8. IBM
9. HOOD
10. DFTX

Go back to Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
(NASDAQ: ACRS) Delayed: 4.84 --0 (-0%)
Previous Close $4.84    52 Week High $33.88 
Open $4.84    52 Week Low $14.12 
Day High $4.84    P/E N/A 
Day Low $4.84    EPS $0.00 
Volume 2,006